Fresenius | FRE - Market Capitalization


Fresenius reported EUR25.51B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akzo Nobel EUR 10.15B 1.73B Jun/2026
Alcon AG USD 33.76B 3.29B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
BASF EUR 41.75B 5.02B Jun/2026
Bayer EUR 47.56B 8.87B Jun/2026
DaVita Healthcare Partners USD 14.23B 3.96B Jun/2026
Demant DKK 56.79B 10.78B Jun/2026
E.ON EUR 47.61B 1.96B Jun/2026
Essilor EUR 76.16B 48.88B Jun/2026
Fresenius EUR 22.51B 2.45B Jun/2026
Fresenius Medical Care EUR 10.55B 766.96M Jun/2026
Getinge SEK 53.96B 1.2B Jun/2026
Givaudan CHF 29.05B 6.42B Dec/2025
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
GN Store Nord DKK 13.17B 2.05B Jun/2026
GRIFOLS EUR 5.41B 181.49M Jun/2026
Hikma Pharmaceutical USD 4.63B 1.42B Dec/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 18.98B 27.8B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Philips EUR 23.09B 615.44M Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
RWE EUR 44.16B 1.26B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Smith & Nephew USD 12.7B 621.83M Jun/2026